|
NUDCD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.695500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.801080E-03 |
| Normal-vs-Stage2 |
5.048800E-01 |
| Normal-vs-Stage3 |
6.013200E-01 |
| Normal-vs-Stage4 |
5.024600E-01 |
| Stage1-vs-Stage2 |
3.303600E-01 |
| Stage1-vs-Stage3 |
1.247810E-02 |
| Stage1-vs-Stage4 |
3.921900E-02 |
| Stage2-vs-Stage3 |
3.732400E-01 |
| Stage2-vs-Stage4 |
3.163800E-01 |
| Stage3-vs-Stage4 |
7.848200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.556000E-02 |
| Normal-vs-AfricanAmerican |
3.750400E-02 |
| Normal-vs-Asian |
7.502600E-01 |
| Caucasian-vs-AfricanAmerican |
6.815400E-01 |
| Caucasian-vs-Asian |
8.155800E-01 |
| AfricanAmerican-vs-Asian |
6.750000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.880980E-03 |
| Normal-vs-Female |
6.915200E-01 |
| Male-vs-Female |
8.376400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.334000E-02 |
| Normal-vs-Extreme_Weight |
1.603550E-03 |
| Normal-vs-Obese |
7.214000E-01 |
| Normal-vs-Extreme_Obese |
5.760300E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.163600E-01 |
| Normal_Weight-vs-Obese |
1.359220E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.911400E-01 |
| Extreme_Weight-vs-Obese |
4.566400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.486400E-01 |
| Obese-vs-Extreme_Obese |
2.006400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.422300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.931200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.177600E-04 |
| Normal-vs-Age(81-100Yrs) |
2.219500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.174400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.819500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.643800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.077670E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.898200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.796960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.120100E-03 |
| Normal-VS-Type2 PRCC |
1.378760E-03 |
| Normal-VS-KIRP CIMP |
8.903400E-03 |
| Normal-VS-Unclassified PRCC |
4.310200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.813600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.404900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.652400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.464100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.368620E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.31359999999637E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.857610E-03 |
| Normal-vs-N1 |
4.003600E-02 |
| Normal-vs-N2 |
5.980000E-01 |
| N0-vs-N1 |
1.803540E-03 |
| N0-vs-N2 |
3.237200E-01 |
| N1-vs-N2 |
7.532200E-01 |
|
|
